NDC 0555-0776 – Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Saccharate 3.125 mg/1; Amphetamine Aspartate Monohydrate 3.125 mg/1; Dextroamphetamine Sulfate 3.125 mg/1; Amphetamine Sulfate 3.125 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII 8 recalls

Product NDC0555-0776

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA040422
Marketed since
March 19, 2003
Listing expires
December 31, 2026
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
0555-0776-02100 TABLET in 1 BOTTLE (0555-0776-02)Mar 19, 2003

Recalls mentioning this NDC

Other Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate products